Principal Financial Group Inc Moderna, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 364,233 shares of MRNA stock, worth $23.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

364,233

Previous 363,905 0.09%

Holding current value

$23.9 Million

Previous $38.8 Million 11.54%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$101.21 - $166.61 $33,196 - $54,648	328 Added 0.09%	364,233 $43.3 Million
Q1 2024 Apr 29, 2024	BUY	$85.37 - $115.44 $251,670 - $340,317	2,948 Added 0.82%	363,905 $38.8 Million
Q4 2023 Feb 07, 2024	SELL	$69.51 - $104.43 $135,474 - $203,534	-1,949 Reduced 0.54%	360,957 $35.9 Million
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $71,536 - $93,944	742 Added 0.2%	362,906 $37.5 Million
Q2 2023 Aug 07, 2023	SELL	$118.5 - $160.53 $2.06 Million - $2.79 Million	-17,351 Reduced 4.57%	362,164 $44 Million
Q1 2023 May 09, 2023	BUY	$135.66 - $197.02 $761,595 - $1.11 Million	5,614 Added 1.5%	379,515 $58.3 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $2.01 Million - $3.56 Million	-16,962 Reduced 4.34%	373,901 $67.2 Million
Q3 2022 Nov 09, 2022	SELL	$118.07 - $194.18 $2.23 Million - $3.67 Million	-18,924 Reduced 4.62%	390,863 $46.2 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $2.21 Million - $3.33 Million	-18,835 Reduced 4.39%	409,787 $58.5 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $59,183 - $110,003	-468 Reduced 0.11%	428,622 $73.8 Million
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $1.87 Million - $3.06 Million	-8,293 Reduced 1.9%	429,090 $109 Million
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $89.3 Million - $195 Million	402,212 Added 1143.59%	437,383 $168 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $7.84 Million - $14.2 Million	-60,326 Reduced 63.17%	35,171 $8.26 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $507,468 - $864,435	4,648 Added 5.12%	95,497 $12.5 Million
Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $854,028 - $2.21 Million	-12,991 Reduced 12.51%	90,849 $9.49 Million
Q3 2020 Nov 06, 2020	SELL	$54.34 - $94.85 $316,693 - $552,785	-5,828 Reduced 5.31%	103,840 $7.35 Million
Q2 2020 Aug 05, 2020	BUY	$29.67 - $80.0 $1.02 Million - $2.74 Million	34,291 Added 45.49%	109,668 $7.04 Million
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $89,060 - $158,184	5,009 Added 7.12%	75,377 $2.26 Million
Q4 2019 Feb 05, 2020	BUY	$13.93 - $21.28 $271,384 - $414,576	19,482 Added 38.29%	70,368 $1.38 Million
Q3 2019 Nov 13, 2019	SELL	$12.26 - $18.07 $294 - $433	-24 Reduced 0.05%	50,886 $810,000
Q2 2019 Aug 12, 2019	BUY	$13.7 - $28.34 $697,467 - $1.44 Million	50,910 New	50,910 $745,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Moderna, Inc. Transaction History